Home › Funds › Blue Owl Capital Holdings LP › LENZ

Blue Owl Capital Holdings LP position in LENZ

LENZ THERAPEUTICS INC · Health Care

Blue Owl Capital Holdings LP reported holding 781,722 shares of LENZ (LENZ THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.56% of its reported portfolio and ranking #27 among its reported holdings. Blue Owl Capital Holdings LP has disclosed LENZ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)781.72K sh
Reported value held$3.00M
Portfolio Weight0.56%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's LENZ position evolved

Blue Owl Capital Holdings LP first disclosed a stake in LENZ in Q4 2025 at 150,000 shares (US$2.4M). The position peaked in Q1 2026 at 506,722 shares, worth US$4.6M. Across 4 filings, Blue Owl Capital Holdings LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 781,722 shares valued at US$3.0M — an increase of 25,000 shares quarter over quarter.. Notable position changes include a 238% increase in Q1 2026 (shares fell 38% over the following quarter), a 49% increase in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 150.00K $2.40M New
Q1 2026 506.72K $4.64M Add
Q2 2026 756.72K $4.30M Add
Q3 2026 781.72K $3.00M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LENZ and 13F data

LENZ (LENZ THERAPEUTICS INC) is a Health Care company. 19 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$20.5M), Versant Venture Management, LLC (US$15.1M), 72 Investment Holdings, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LENZ

All LENZ fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held LENZ?

Blue Owl Capital Holdings LP has disclosed LENZ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Blue Owl Capital Holdings LP's current position in LENZ?

As of Q3 2026, Blue Owl Capital Holdings LP holds 781.72K shares of LENZ (LENZ THERAPEUTICS INC), valued at $3.00M, representing 0.56% of its reported portfolio and ranking #27.

Has Blue Owl Capital Holdings LP been buying or selling LENZ?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in LENZ. The position peaked in Q1 2026 at 506.72K shares.

Which other funds hold LENZ?

Other major institutional holders of LENZ include Alpha Wave Global, LP, Versant Venture Management, LLC, 72 Investment Holdings, LLC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.